Enanta Pharmaceuticals reported $26.62M in Current Liabilities for its first fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Current Liabilities Change
Acorda Therapeutics ACOR:US $ 133.05M 4.2M
Amgen AMGN:US $ 12869M 1216M
Anika Therapeutics ANIK:US $ 46.97M 10.11M
Arrowhead Research ARWR:US $ 167.19M 142.09M
AstraZeneca AZN:LN 21513M 1206M
Biocryst Pharmaceuticals BCRX:US $ 101.2M 4.45M
Biogen BIIB:US $ 3347.2M 181.4M
Bristol Myers Squibb BMY:US $ 17330M 1750M
Clovis Oncology CLVS:US $ 173.24M 11.69M
Enanta Pharmaceuticals ENTA:US $ 26.62M 3.57M
Gilead Sciences GILD:US $ 9705M 1692M
GlaxoSmithKline GSK:LN 20275M 1873M
Halozyme Therapeutics HALO:US $ 107.42M 313.96M
Heron Therapeutics HRTX:US $ 100.92M 1.59M
Insmed INSM:US $ 81.4M 37.41M
Intercept Pharmaceuticals ICPT:US $ 146.23M 32.84M
IONIS PHARMACEUT IONS:US $ 295.1M 288.14M
Karyopharm Therapeutics KPTI:US $ 62.01M 1.8M
Ligand Pharmaceuticals LGND:US $ 95.8M 4.31M
Marinus Pharmaceuticals MRNS:US $ 16.12M 5.39M
Neurocrine Biosciences NBIX:US $ 190M 3.5M
Novartis NOVN:VX SF 30160M 2899M
Novavax NVAX:US $ 1208.56M 628.88M
Ptc Therapeutics PTCT:US $ 250.95M 26.38M
Sarepta Therapeutics SRPT:US $ 364.74M 51.29M
Vertex Pharmaceuticals VRTX:US $ 1659.88M 217.66M
Vital Therapies VTL:US $ 16.36M 7.96M
YTE INCY:US $ 670.59M 39.4M